Key result
ECV outperforms precontrast T1 for detecting MI and better predicts functional recovery than LGE.
Why the study?
The utility of myocardial extracellular volume fraction measurement by cardiac MR to indicate myocardial injury, angiographic collateral flow, and functional recovery in CTO patients was unclear.
Does myocardial extracellular volume fraction (ECV) measurement by cardiac MR improve the assessment of myocardial injury, collateral flow, and functional recovery compared to LGE in patients with chronic total coronary occlusion?
Observational (n=50)
Does myocardial extracellular volume fraction (ECV) measurement by cardiac MR improve the assessment of myocardial injury, collateral flow, and functional recovery compared to LGE in patients with chronic total coronary occlusion?
p-value: p=<0.02
Myocardial ECV by cardiac MR provides incremental value over LGE for predicting functional recovery and assessing myocardial injury in patients with chronic total coronary occlusion.
May refine CTO viability assessment beyond LGE; leaves open whether ECV alters revascularization decisions.
PURPOSE: To investigate whether myocardial extracellular volume fraction (ECV) measurement by cardiac MR is indicative of myocardial injury, angiographic collateral flow, and functional recovery in patients with chronic total coronary occlusion (CTO). MATERIALS AND METHODS: A total of 50 CTO patients undergoing 1.5 Tesla MR were prospectively enrolled, and 28 underwent a second MR 6 months after revascularization. T1-mapping based indices, including pre- and postcontrast T1 values and ECV, were obtained from infarcted and non-infarcted myocardium, myocardial segments, and coronary territory. The severity of myocardial injury was rated by transmurality extent of infarction (TEI) and regional wall motion abnormalities (RWMA) score. Angiographic collateral flow was evaluated using Rentrop classification. Improvement in segmental wall motion at 6 months was also assessed. RESULTS: ECV and postcontrast T1 value significantly outperformed precontrast T1 value for identifying myocardial infarction (area under the receiver operating characteristic curve [AUC]: 0.998 and 0.953 versus 0.824, all P < 0.02). Myocardial ECV was strongly correlated with TEI (P = 0.000), RWMA score (P = 0.000), and collateral classification (P = 0.007 for left anterior descending artery [LAD] territory, P = 0.001 for non-LAD territory). Furthermore, the likelihood of functional recovery was better predicted by ECV than by late gadolinium enhancement (LGE) (AUC: 0.76 versus 0.68, P < 0.02). CONCLUSION: Myocardial ECV may be a useful surrogate to assess myocardial injury and angiographic collateral flow in CTO, and ECV provides incremental value to LGE in assessing functional recovery after revascularization. J. MAGN. RESON. IMAGING 2016;44:972-982.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2016) conducted an observational in Chronic total coronary occlusion (CTO) (n=50). Myocardial extracellular volume fraction (ECV) measurement vs. Precontrast T1 value and late gadolinium enhancement (LGE) was evaluated on Identifying myocardial infarction and predicting functional recovery (p=<0.02). Myocardial ECV outperformed precontrast T1 for identifying myocardial infarction (AUC 0.998 vs 0.824, P<0.02) and better predicted functional recovery than LGE (AUC 0.76 vs 0.68, P<0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: